
Buy now, save later: financing vaccine candidates
The Intelligence from The Economist
00:00
Intro
This chapter examines the competitive arena of COVID-19 vaccine development, detailing over 170 candidates with six in advanced trials. It addresses the challenges of funding allocation and the critical need for equitable global access to vaccines, emphasizing the moral obligation to protect all lives.
Transcript
Play full episode